Isofol’s board appoints Thomas Andersson as new CEO of the company

Gothenburg, Sweden, February 28, 2023 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the board of Isofol has decided to appoint Thomas Andersson as CEO of the company from February 28, 2023. As a consequence of this decision, the current CEO, Ulf Jungnelius, is resigning and is now being dismissed from his position.

Isofol’s board appoints Thomas Andersson as new CEO of the company Read More »